In the last two decades, non-alcoholic fatty liver disease (NAFLD), has transitioned from a non-existent entity to become one of the leading etiologies of chronic liver disease in the world.
Editorial
Liver transplantation in patients with non-alcoholic steatohepatitis and alcohol-related liver disease: the dust is yet to settle
Review Article
Peri-transplant management of nonalcoholic fatty liver disease in liver transplant candidates
Evaluation of liver transplant candidates with non-alcoholic steatohepatitis
Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation
Bariatric surgery, obesity and liver transplantation
Pre-transplant portal vein thrombosis in non-alcoholic fatty liver disease patients—pathogenesis, risk factors, and implications on management
Peri-transplant renal dysfunction in patients with non-alcoholic steatohepatitis undergoing liver transplantation
Liver transplantation for alcoholic hepatitis
Metabolic syndrome following liver transplantation in nonalcoholic steatohepatitis
Multimodal multidisciplinary management of alcohol use disorder in liver transplant candidates and recipients
Ethical and allocation issues in liver transplant candidates with alcohol related liver disease
Nonalcoholic steatohepatitis recurrence after liver transplant
Post-transplant malignancies in alcoholic liver disease
Approach to prevention of non-alcoholic fatty liver disease after liver transplantation
Acute-on-chronic liver failure in liver transplant candidates with non-alcoholic steatohepatitis
Implications of pre-transplant sarcopenia and frailty in patients with non-alcoholic steatohepatitis and alcoholic liver disease
Disclosure:
The series “Liver Transplantation in NASH and ALD” was commissioned by the editorial office, Translational Gastroenterology and Hepatology without any sponsorship or funding. Sanjaya Satapathy, David E. Bernstein and Nitzan C. Roth served as the unpaid Guest Editors for the series.